Sarah Monroe once had a relatively comfortable middle-class life. She and her family lived in a neatly landscaped neighborhood near Cleveland. They had a six-figure income and health insurance. Then, four years ago, when Monroe was pregnant with twin girls, something started to feel off. “I kept having to come into the emergency room for…
David Garza sometimes feels as if he doesn’t have health insurance now that he pays so much to treat his Type 2 diabetes. His monthly premium payment of $435 for family coverage is roughly the same as the insurance at his previous job. But the policy at his current job carries an annual deductible of…
There are four primary types of uncertainty in health economic modelling: Heterogeneity: Variation between individuals that can be explained by their characteristicsStochastic uncertainty: Variation between individuals that cannot be explained by their characteristics, Parameter uncertainty: Uncertainty in the estimated values for the parameters that define the modelStructural uncertainty: Uncertainty in model outcomes that arise from…
That is the title of a paper by Longo et al. (2025). The authors use dynamic panel data on Adult Social Care (ASC) in the UK. What is ASC include: A quick explainer about ASC in the UK: In England, there are 152 upper-tier local authorities (LAs) who are responsible for publicly-funded ASC services. Access…
Theranostics — which combines molecular imaging with targeted therapy — is quickly becoming a significant innovation in cancer care, offering more precise treatment with fewer side effects. GE Healthcare expects the field to grow rapidly over the next decade, as long as hospitals can continue to invest in the imaging and software infrastructure needed to…
GSK submitted the same Blenrep clinical trial data to global regulators and the FDA, but received a slightly more limited regulatory approval in the U.S. In an interview during the annual meeting of the American Society of Hematology, GSK oncology executive Hesham Abdullah explained what else the FDA wants from Blenrep clinical trials. The post…
The fake products are visually similar to authentic ones but can be distinguished by the placement of the EXP/LOT text on the label
Angle Health’s Series B round was led by Portage and included participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator. The post Angle Health Secures $134M to Grow Benefits Platform for Small Businesses appeared first on MedCity News.
The initiative promotes collaboration among HHS agencies to build a unified AI infrastructure
Vulcan Interoperability Bridge Program Manager Sandy Vance discusses plans to launch a second cohort